Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial.
暂无分享,去创建一个
Antonio Colombo | Patrick W Serruys | M. Mack | P. Serruys | F. Mohr | T. Feldman | D. Holmes | M. Morice | A. Colombo | A. Kappetein | K. Dawkins | David R Holmes | E. Ståhle | Elisabeth Ståhle | Friedrich W Mohr | Keith D Dawkins | Michael J Mack | Arie Pieter Kappetein | Marie-Claude Morice | Ted E Feldman
[1] P. Serruys,et al. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study). , 2010, The American journal of cardiology.
[2] M. Kutner,et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST) , 1994, The New England journal of medicine.
[3] P. Serruys,et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. , 2010, Journal of the American College of Cardiology.
[4] Patrick W Serruys,et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. , 2006, American heart journal.
[5] Seung‐Jung Park,et al. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. , 2010, JACC: Cardiovascular Interventions.
[6] F Unger,et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.
[7] P. Shah,et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. , 2006, Journal of the American College of Cardiology.
[8] M. Kutner,et al. A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery , 1994 .
[9] J. Ornato,et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[10] G. Biondi-Zoccai,et al. Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplasty. , 2010, American heart journal.
[11] P. Serruys,et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[12] A. Kiss,et al. Impact of Patient and Target-Vessel Characteristics on Arterial and Venous Bypass Graft Patency: Insight From a Randomized Trial , 2007, Circulation.
[13] A. Kaider,et al. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study. , 2009, JACC. Cardiovascular interventions.
[14] Patrick W Serruys,et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. , 2005, Journal of the American College of Cardiology.
[15] Antonio Colombo,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.
[16] Patrick W Serruys,et al. Coronary-artery stents. , 2006, The New England journal of medicine.
[17] Volkmar Falk,et al. Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .
[18] D. Capodanno,et al. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. , 2009, JACC. Cardiovascular interventions.
[19] Reza Ardehali,et al. Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery , 2007, Annals of Internal Medicine.
[20] M. Mack,et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. , 2011, The Journal of thoracic and cardiovascular surgery.
[21] A. Natarajan,et al. Right heart complications of ventriculoatrial shunt. , 2011, European Heart Journal.
[22] B. Gersh,et al. Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation , 2011 .
[23] F. Eberli,et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. , 2010, Journal of the American College of Cardiology.
[24] P. Serruys,et al. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. , 2007, The American journal of cardiology.
[25] G. Angelini,et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.
[26] J. Forrester,et al. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. , 2007, International journal of cardiology.
[27] G. Stone,et al. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting. , 2010, JACC. Cardiovascular interventions.
[28] V. Fuster,et al. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. , 2008, American heart journal.
[29] P. Teirstein,et al. Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. , 2009, Journal of the American College of Cardiology.
[30] F. Mohr,et al. Does Reasonable Incomplete Surgical Revascularization Affect Early or Long-Term Survival in Patients With Multivessel Coronary Artery Disease Receiving Left Internal Mammary Artery Bypass to Left Anterior Descending Artery? , 2009, Circulation.
[31] L. Mauri,et al. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation , 2007, Current opinion in cardiology.
[32] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[33] M. Mack,et al. Assessment of the SYNTAX score in the Syntax study. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.